[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338066-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338066-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","rgs10-deficiency-facilitates-distant-metastasis-by-inducing-epithelial-mesenchymal-transition-in-breast-cancer","RGS10 deficiency facilitates distant metastasis by inducing epithelial - mesenchymal transition in breast cancer","","Distant metastasis is the major cause of death in breast cancer, and epithelial–mesenchymal transition (EMT) is a key driver of metastatic invasion. The study identifies a novel role for regulator of G protein signaling 10 (RGS10) in regulating EMT and promoting metastasis control. RGS10 protein is significantly reduced in breast tumors, and its deficiency predicts poorer prognosis. RGS10 knockdown enhances EMT and increases migration and invasion, with effects dependent on lipocalin-2 and MIR539-5p, supporting RGS10 as a tumor suppressor, biomarker, and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/rgs10-deficiency-facilitates-distant-metastasis-by-inducing-epithelial-mesenchymal-transition-in-breast-cancer/338066/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/rgs10-deficiency-facilitates-distant-metastasis-by-inducing-epithelial-mesenchymal-transition-in-breast-cancer/338066.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main problem the study addresses in breast cancer?","Question",{"text":63,"@type":64},"Distant metastasis is identified as the major cause of death in breast cancer, and EMT is described as a critical mechanism supporting metastatic invasion.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do RGS10 levels relate to breast cancer progression and patient prognosis?",{"text":68,"@type":64},"RGS10 protein levels are significantly lower in breast cancer tissues than in normal breast tissues, and RGS10 deficiency predicts a worse prognosis.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental effects does RGS10 silencing produce in breast cancer cells?",{"text":72,"@type":64},"Silencing RGS10 in SKBR3 cells enhances EMT and increases cell migration and invasion compared with controls.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338066,1790497594,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \n*For correspondence:  \n[jadegx@163.com](jadegx@163.com)  \n†These authors contributed equally to this work  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 21  \nSent for Review  \n04 March 2024  \nPreprint posted  \n06 March 2024  \nReviewed preprint posted  \n19 April 2024  \nReviewed preprint revised  \n24 May 2024  \nVersion of Record published  \n15 August 2024  \nReviewing Editor: Yaoting Ji, Wuhan University, China  \n Copyright Liu, Jiang, Qiu et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.  \nRGS10 deficiency facilitates distant metastasis by inducing epithelial– mesenchymal transition in breast cancer  \nYang Liu1†, Yi Jiang1†, Peng Qiu2†, Tie Ma3†, Yang Bai4†, Jiawen Bu1, Yueting Hu1, Ming Jin1, Tong Zhu5, Xi Gu1*  \n1 Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; 2 Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China; 3 Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China; 4 Department of Nursing, Shengjing Hospital of China Medical University, Shenyang, China; 5 Breast Surgery of Panjin Central Hospital, Panjin, China  \n\n| Abstract Distant metastasis is the major cause of death in patients with breast cancer. Epithelial–mesenchymal transition (EMT) contributes to breast cancer metastasis. Regulator of G proteinsignaling (RGS) proteins modulates metastasis in various cancers. This study identified a novel role for RGS10 in EMT and metastasis in breast cancer. RGS10 protein levels were significantly lower in breast cancer tissues compared to normal breast tissues, and deficiency in RGS10 protein predicted a worse prognosis in patients with breast cancer. RGS10 protein levels were lower in the highly aggressive cell line MDA-MB-231 than in the poorly aggressive, less invasive cell lines MCF7 and SKBR3 . Silencing RGS10 in SKBR3 cells enhanced EMT and caused SKBR3 cell migration and invasion. The ability of RGS10 to suppress EMT and metastasis in breast cancer was dependent on lipocalin-2 and MIR539-5p. These findings identify RGS10 as a tumor suppressor, prognostic biomarker, and potential therapeutic target for breast cancer. |\n| --- |\n| eLife assessment\u003Cbr>This valuable article first demonstrated that RGS10 was identified as a biomarker to evaluate the prognosis of breast cancer. To prevent the loss of RGS10, it theoretically provides a new strategy for the treatment of breast cancer. The evidence supporting the claims of the authors is solid, although inclusion of a larger number of patient samples and an animal model would have strengthened the study. The work will be of interest to clinicians working on breast cancer. |\n\nIntroduction  \nBreast cancer is the most common cancer among women worldwide. Globally, in 2020, an estimated 2.3 million new cases of breast cancer were diagnosed, and there were approximately 685,000 deaths from the disease (Sung et al., 2021) . The majority of breast cancer mortality is due to distant metastasis, with 5-year survival estimated at 30%(American Cancer Society, 2023) . There is a critical need to identify early breast cancer metastasis using prognostic biomarkers to ensure patients receive effective anticancer therapies in a timely manner (Miglietta et al., 2022) .  \nEpithelial–mesenchymal transition (EMT) plays a critical role in tumor progression and metastatic invasion in breast cancer. EMT describes the process by which epithelial cells lose their epithelial characteristics and cell–cell contact and increase their invasive potential (Singh and Chakrabarti, 2019) .  \nLiu, Jiang, Qiu et al. eLife 2024;13:RP97327. DOI: [https://doi.org/10.7554/eLife.97327](https://doi.org/10.7554/eLife.97327) 1 of 24  \n Research article Cancer Biology  \nEMT is characterize","cbCaicjSyB2sCpNQ","https://ap.wps.com/l/cbCaicjSyB2sCpNQ","pdf",12364414,24,"English","# Abstract\n# Introduction\n## Epidemiology and need for prognostic biomarkers\n## EMT as a driver of tumor progression\n## RGS proteins and prior evidence for RGS10","[{\"question\":\"What is the main problem the study addresses in breast cancer?\",\"answer\":\"Distant metastasis is identified as the major cause of death in breast cancer, and EMT is described as a critical mechanism supporting metastatic invasion.\"},{\"question\":\"How do RGS10 levels relate to breast cancer progression and patient prognosis?\",\"answer\":\"RGS10 protein levels are significantly lower in breast cancer tissues than in normal breast tissues, and RGS10 deficiency predicts a worse prognosis.\"},{\"question\":\"What experimental effects does RGS10 silencing produce in breast cancer cells?\",\"answer\":\"Silencing RGS10 in SKBR3 cells enhances EMT and increases cell migration and invasion compared with controls.\"}]","RGS10 deficiency facilitates distant metastasis by inducing epithelial - mesenchymal transition in breast cancer | PDF",1790021797,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cad841e397b65f41b44fe3225c7ef4a.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8bd21094e38d0880cb14e5e70e21e08.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbcfd277cbb82231edbf5667cfbb83a2.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00601c2276406af7ae6feaa529d672cd.webp",980,1268]